Difficult to treat Asthma Australia
Our Difficult-To-Treat Asthma Audit is proving successful in Australia and we are getting great feedback. One
Our Difficult-To-Treat Asthma Audit is proving successful in Australia and we are getting great feedback. One
The February issue of REG’s newsletter is out – and ISAR has been featured in
Optimum Patient Care Australia is a social enterprise improving the diagnosis, treatment and management of chronic diseases within primary care.
Cluster Analysis of Inflammatory Biomarker Expression in the International Severe Asthma Registry This study used
International Severe Asthma Registry (ISAR) aims to offer a rich source of real-life data for